Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a -54.609% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Cn1nnc2cc(C(=O)N3CCCCCC3)ccc21
b.) Clc1cccc(-c2nc(NCc3cccnc3)c3ccccc3n2)c1
c.) C=CCn1c(SCC(=O)NC2CC2)nc2sc(CC)cc2c1=O
Answer: c. C=CCn1c(SCC(=O)NC2CC2)nc2sc(CC)cc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C=CCn1c(SCC(=O)NC2CC2)nc2sc(CC)cc2c1=O
C=CCn1c(SCC(=O)NC2CC2)nc2sc(CC)cc2c1=O
N-cyclopropyl-2-(6-ethyl-4-oxo-3-prop-2-enylthieno[2,3-d]pyrimidin-2-yl)sulfanylacetamide